11Aug
COVID Impact as a Standalone Indemnity in M&A Transactions
Introduction - The COVID virus has ushered in unprecedented and challenging times for our country and the global community. From the deeply personal pain and suffering caused by the virus as a health pandemic to behavioral adjustments in the consumer population at large (“social distancing,” etc.), to every day, but very real, burdens created by business closures and shelter in place orders, the full force and impact of the virus on our society won’t be known for a long time....
By:
Goulston & Storrs PC
Related
On April 27, 2020, and as part of its response to the COVID-19 pandemic, the Bureau issued a stateme...
Read More >
On July 1, 2019, the Equal Employment Opportunity Commission (EEOC) updated the Component 2 filing s...
Read More >
The Mississippi Commission on Environmental Quality (“MCEQ”) and Dixie Springs Enterprises, LLC (“...
Read More >
The court granted Aetna’s motion to compel arbitration of a former employee’s age and disability w...
Read More >
Speed read - New merger control guidelines in Indonesia provide that asset acquisitions are now tra...
Read More >
The non-disclosure provision of a routine employment settlement agreement has typically been a commo...
Read More >